1 / 4

Investing in Hepatitis: Advocacy for Funding and Strategies

Learn about the current investment landscape in hepatitis funding and the urgent need for new advocacy tools. Despite limited funding allocated, there is a critical need for more support in this area. Discover ways you can contribute and make a difference by working with advocacy groups, identifying funding sources, sharing expertise, and more. Find out about the National Viral Hepatitis Roundtable and how you can get involved in advocating for better resources. Contact Chris Taylor, Associate Director of Viral Hepatitis, for more information.

ellard
Download Presentation

Investing in Hepatitis: Advocacy for Funding and Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village Session July 23, 2012

  2. The Budget Landscape • Very little funding dedicated to viral hepatitis • US – CDC Division of Viral Hepatitis ~$30 million • US – NIH ~$100 million • US – Other agencies – very little to no dedicated funding • WHO – very few staff assigned to viral hepatitis • Need greatly outweighs available funding • Relying on public/private partnerships

  3. How You Can Help! • Work with hepatitis advocates in your area • Assist with identifying hepatitis funding while conducting HIV resource tracking • Carry hepatitis advocacy messages • Look at co-infection rates and develop a strategy • Ask like-minded donors to consider hepatitis also • Share your expertise about resource tracking

  4. World Hepatitis Alliance • www.worldhepatitisalliance.org • National Viral Hepatitis Roundtable • www.nvhr.org Chris Taylor Associate Director, Viral Hepatitis 202.434.8090 ctaylor@NASTAD.org

More Related